RGIN Financials 07/16/2014 01:21:56
Regenicin, Inc.
Period Ending Sep 30, 2013 Sep 30, 2012 Sep 30, 2011 Sep 30, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 80 965 519 -
Sales, General and Admin. 918 1,394 3,521 679
Non-Recurring Items 3,000 - - -
Other - - - -
Operating Income (3,998) (2,359) (4,040) (679)
Income From Continuing Operations
Add'l Income/Expense Items (140) - - -
Earnings Before Interest and Tax (4,138) (2,359) (4,040) (679)
Interest Expense 767 788 7 256
Earnings Before Tax (4,905) (3,147) (4,046) (935)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,905) (3,147) (4,046) (935)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,905) (3,147) (4,046) (935)
Preferred Stock and Other Adjustments (46) (108) (1,371) -
Net Income Applicable to Common Shareholders (4,951) (3,255) (5,418) (935)